| CAS ID: | 59-02-9 |
| Molecular Formula: | C29H50O2 |
| Molecular Weight: | 430.7 g/mol |
| Monoisotopic Mass: | 430.3811 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | Alpha Tocopherol | Tocopherol | Tocopherol (Vit E) | Vitamin E | Aquasol E | E307 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1 | See All |
| InChI Key: | GVJHHUAWPYXKBD-IEOSBIPESA-N | |
| Smiles: | CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00583700 | Disease | Fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | December 31, 2007 | Last Verified | January 29, 2013 |
| Sponsor | University of Iowa | ||
Trial Record 2
| ClinicalTrial ID | NCT01935817 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | September 5, 2013 | Last Verified | September 5, 2013 |
| Sponsor | University of Catania | ||
Trial Record 3
| ClinicalTrial ID | NCT02690064 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Recruiting |
| First Received | February 24, 2016 | Last Verified | January 10, 2018 |
| Sponsor | Augusta University | ||
Trial Record 4
| ClinicalTrial ID | NCT00655018 | Disease | Liver fibrosis |
| Phase | Phase 2,Phase 3 | Status | Completed |
| First Received | April 9, 2008 | Last Verified | April 9, 2008 |
| Sponsor | Bambino Gesù Hospital and Research Institute | ||
Trial Record 5
| ClinicalTrial ID | NCT01934777 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | September 4, 2013 | Last Verified | January 14, 2016 |
| Sponsor | Bambino Gesù Hospital and Research Institute | ||
Trial Record 6
| ClinicalTrial ID | NCT00022204 | Disease | Pulmonary fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | February 4, 2004 | Last Verified | November 6, 2013 |
| Sponsor | Royal Marsden NHS Foundation Trust | ||
Trial Record 7
| ClinicalTrial ID | NCT03176966 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Enrolling by invitation |
| First Received | June 6, 2017 | Last Verified | June 13, 2018 |
| Sponsor | Vanderbilt University Medical Center | ||